APAC Pharmacovigilance Standards Overview 2016
APAC is the third largest pharmaceutical market in the world, worth over USD 140 billion and rapidly growing. This increased market demand and activity brings an increased focus on pharmacovigilance, (PV) and drug safety. To accompany the growing importance of this topic, this eBook provides an overview of the PV regulations across several of the major markets in the APAC region, as well as an analysis of the key challenges obstructing PV harmonisation.
Please note: That all fields marked with an asterisk (*) are required.